Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
41 hedge funds and large institutions have $242M invested in Dimension Therapeutics, Inc in 2015 Q4 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$88.6M |
| 2 |
O
OrbiMed
New York
|
+$68.3M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
+$26.1M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$15.6M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$15.3M |
Top Sellers
DMTX Hedge Fund Activity: Q4 2015 in Review
41 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q4 2015, worth a combined $242M.
Buyers outnumbered sellers: 41 funds opened new DMTX positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $88.6M.
- 41 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $242M of Dimension Therapeutics, Inc stock for Q4 2015.
- 41 funds opened new Dimension Therapeutics, Inc positions in Q4 2015 and 0 closed out, a net change of +41 holders.
- The largest Dimension Therapeutics, Inc buyer in Q4 2015 was Fidelity Investments, an estimated $88.6M added.
Based on aggregated 13F filings for Q4 2015.